In contrast to BRCA1 and BRCA2, for which functional assays calibrated to breast cancer risk in terms of specificity and sensitivity are available, no such assays currently exist for the classification of PALB2 variants, mainly due to the lack of family-based data of truly pathogenic missense variants. Here, BRCA2 is linked to breast carcinoma.